Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Description
Control Bionics Ltd. engages in the manufacture, design, and sale of wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. It operates through the following segments: Australia, US, International, R&D, and Corporate. The Australia segment is involved with the sales of Trilogy units and components in Australia. The US segment refers to Manufacture and sales of Trilogy units and components in North America. The International segment deals with the activities undertaken to establish viable and additional operating segments. The R&D segment pertains to the Research activities undertaken regarding the Group's products. The Corporate segment offers support, regulatory and infrastructure activities, and elimination entries above the EBITDA line. The company was founded by Peter Shann Ford in 2005 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.03 - 0.08
Trade Value (12mth)
AU$2,144.00
1 week
-1.85%
1 month
6%
YTD
-1.85%
1 year
-30.86%
All time high
1.12
EPS 3 yr Growth
365.300%
EBITDA Margin
-99.20%
Operating Cashflow
-$5m
Free Cash Flow Return
-47.20%
ROIC
-58.70%
Interest Coverage
-262.40
Quick Ratio
2.00
Shares on Issue (Fully Dilluted)
106m
HALO Sector
Technology
Next Company Report Date
21-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
27 June 24 |
Letter to Shareholders
×
Letter to Shareholders |
24 June 24 |
Change of Director's Interest Notice - Ford
×
Change of Director's Interest Notice - Ford |
20 June 24 |
TGA Approval Granted for DROVE Autonomous Wheelchair Module
×
TGA Approval Granted for DROVE Autonomous Wheelchair Module |
14 June 24 |
Change of Director's Interest Notice - Ford
×
Change of Director's Interest Notice - Ford |
04 June 24 |
Change in substantial holding - Ford
×
Change in substantial holding - Ford |
03 June 24 |
Change of Director's Interest Notice - Ford
×
Change of Director's Interest Notice - Ford |
31 May 24 |
CEO to speak at United Nations AI for Good Summit
×
CEO to speak at United Nations AI for Good Summit |
31 May 24 |
CBL presentation at United Nations AI for Good Summit
×
CBL presentation at United Nations AI for Good Summit |
27 May 24 |
Application for quotation of securities - CBL
×
Application for quotation of securities - CBL |
27 May 24 |
Cleansing notice
×
Cleansing notice |
27 May 24 |
Notification regarding unquoted securities - CBL
×
Notification regarding unquoted securities - CBL |
17 May 24 |
Control Bionics increases placement
×
Control Bionics increases placement |
17 May 24 |
Update - Proposed issue of securities - CBL
×
Update - Proposed issue of securities - CBL |
15 May 24 |
Control Bionics completes successful $1.04m placement
×
Control Bionics completes successful $1.04m placement |
15 May 24 |
Proposed issue of securities - CBL
×
Proposed issue of securities - CBL |
13 May 24 |
Trading Halt
×
Trading Halt |
13 May 24 |
CBL Appoints Lynx Advisors as Corporate Advisor
×
CBL Appoints Lynx Advisors as Corporate Advisor |
13 May 24 |
Notification regarding unquoted securities - CBL
×
Notification regarding unquoted securities - CBL |
13 May 24 |
Notification regarding unquoted securities - CBL
×
Notification regarding unquoted securities - CBL |
09 May 24 |
Appointment of CFO
×
Appointment of CFO |
08 May 24 |
Contract award US General Services Administration
×
Contract award US General Services Administration |
07 May 24 |
Japan Partnership
×
Japan Partnership |
06 May 24 |
Amended Appendix 4C
×
Amended Appendix 4C |
26 April 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
23 April 24 |
Investor Presentation
×
Investor Presentation |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.